Watson Pharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial ReportiCD ResearchFebruary 4, 2012 42 Pages - SKU: ICDR6792555 |
| Synopsis ICD Research's Watson Pharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, competitive benchmarking, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company. Summary ICD Research's Watson Pharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report is a crucial resource for industry executives and anyone looking to access key information about Watson Pharmaceuticals, Inc.. ICD Research's Watson Pharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
Watson Pharmaceuticals, Inc., (Watson) is a specialty pharmaceutical company that develops, manufactures and markets branded and generic pharmaceutical products in the field of central nervous system, hormones and synthetic substitutes, cardiovascular, gastrointestinal and nephrology, among others. The company commercializes about 160 generic pharmaceutical products and 30 branded pharmaceutical products. It markets generic products to various drug wholesalers, mail order, government and national retail drug and food store chains. Its generic prescription products are marketed under 'Watson Laboratories' and 'Watson Pharma' labels and over-the-counter generics under 'Rugby' label or private label. The company operates in around 20 countries. Watson is headquartered in Parsippany, New Jersey. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

